-
Je něco špatně v tomto záznamu ?
High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer
LA. Syding, K. Plačková, L. Pavelková, C. Aquino-Perez, SJ. Santegoets, J. Laco, M. Grega, P. Dundr, K. Němejcová, M. Hodek, J. Bouček, M. Zábrodský, H. Vošmiková, MJ. Halaška, L. Rob, P. Čelakovský, V. Chrobok, MN. Iheme, I. Práznovec, M....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral Open Access
od 2013
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-05-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Health & Medicine (ProQuest)
od 2013-05-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
40998518
DOI
10.1136/jitc-2025-012613
Knihovny.cz E-zdroje
- MeSH
- dlaždicobuněčné karcinomy hlavy a krku imunologie MeSH
- ektopické lymfoidní struktury * imunologie patologie MeSH
- infekce papilomavirem * komplikace imunologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- myeloidní supresorové buňky * imunologie metabolismus MeSH
- nádory děložního čípku * imunologie patologie mortalita MeSH
- prognóza MeSH
- regulační T-lymfocyty * imunologie metabolismus MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: High densities of tertiary lymphoid structures (TLSs) are associated with improved clinical outcomes in various malignancies, including human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC). However, the role of TLSs in shaping antitumor immunity in HPV-induced cervical cancer (CESC) remains unclear. Therefore, we analyzed the density, composition, and prognostic impact of TLSs in patients with CESC as well as patients with HNSCC. METHODS: Multiplex immunofluorescence, immunohistochemistry, and spatial transcriptomics were used to analyze TLS density and composition in HNSCC and CESC tissue sections with respect to patient prognosis. The spatial approach was supplemented by flow cytometry-based analysis of the polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) phenotype in freshly resected primary tumor tissues. RESULTS: Although both indications were associated with HPV infection, we confirmed a positive correlation between TLS density and improved overall survival only in patients with HNSCC. The TLS composition differed markedly between HNSCC and CESC samples, with a shift toward high regulatory T cell (Treg) and PMN-MDSC abundance in CESC samples. The highest Treg and PMN-MDSC levels were observed in patients with CESC who died of the disease. CESC-infiltrating PMN-MDSCs showed high arginase 1 expression, which correlated with diminished T-cell receptor (TCR)ζ chain expression in CESC-infiltrating T cells. Additionally, the high number of PMN-MDSCs in TLSs was associated with the absence of HPV-specific T cells in CESC. CONCLUSIONS: Unlike in HNSCC, the composition of TLSs, rather than their quantity, was associated with the overall survival of patients with CESC. High numbers of Tregs and PMN-MDSCs infiltrating immature TLSs prevail in patients with CESC who succumbed to the disease and seem to affect tumor-specific immune responses.
1st Faculty of Medicine Charles University Prague Czech Republic
Department of Medical Oncology Leiden University Medical Center Leiden The Netherlands
Department of Pathology and Molecular Medicine Motol University Hospital Prague Czech Republic
Department of Pathology General University Hospital Prague Czech Republic
Fingerland Department of Pathology University Hospital Hradec Kralove Hradec Kralove Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25021532
- 003
- CZ-PrNML
- 005
- 20251023075709.0
- 007
- ta
- 008
- 251014s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/jitc-2025-012613 $2 doi
- 035 __
- $a (PubMed)40998518
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Syding, Linn A $u Sotio Biotech a.s, Prague, Czech Republic
- 245 10
- $a High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer / $c LA. Syding, K. Plačková, L. Pavelková, C. Aquino-Perez, SJ. Santegoets, J. Laco, M. Grega, P. Dundr, K. Němejcová, M. Hodek, J. Bouček, M. Zábrodský, H. Vošmiková, MJ. Halaška, L. Rob, P. Čelakovský, V. Chrobok, MN. Iheme, I. Práznovec, M. Vošmik, S. Katina, D. Cibula, A. Ryška, SH. van der Burg, R. Špíšek, A. Fialová
- 520 9_
- $a BACKGROUND: High densities of tertiary lymphoid structures (TLSs) are associated with improved clinical outcomes in various malignancies, including human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC). However, the role of TLSs in shaping antitumor immunity in HPV-induced cervical cancer (CESC) remains unclear. Therefore, we analyzed the density, composition, and prognostic impact of TLSs in patients with CESC as well as patients with HNSCC. METHODS: Multiplex immunofluorescence, immunohistochemistry, and spatial transcriptomics were used to analyze TLS density and composition in HNSCC and CESC tissue sections with respect to patient prognosis. The spatial approach was supplemented by flow cytometry-based analysis of the polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) phenotype in freshly resected primary tumor tissues. RESULTS: Although both indications were associated with HPV infection, we confirmed a positive correlation between TLS density and improved overall survival only in patients with HNSCC. The TLS composition differed markedly between HNSCC and CESC samples, with a shift toward high regulatory T cell (Treg) and PMN-MDSC abundance in CESC samples. The highest Treg and PMN-MDSC levels were observed in patients with CESC who died of the disease. CESC-infiltrating PMN-MDSCs showed high arginase 1 expression, which correlated with diminished T-cell receptor (TCR)ζ chain expression in CESC-infiltrating T cells. Additionally, the high number of PMN-MDSCs in TLSs was associated with the absence of HPV-specific T cells in CESC. CONCLUSIONS: Unlike in HNSCC, the composition of TLSs, rather than their quantity, was associated with the overall survival of patients with CESC. High numbers of Tregs and PMN-MDSCs infiltrating immature TLSs prevail in patients with CESC who succumbed to the disease and seem to affect tumor-specific immune responses.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a nádory děložního čípku $x imunologie $x patologie $x mortalita $7 D002583
- 650 12
- $a regulační T-lymfocyty $x imunologie $x metabolismus $7 D050378
- 650 12
- $a ektopické lymfoidní struktury $x imunologie $x patologie $7 D000072717
- 650 12
- $a myeloidní supresorové buňky $x imunologie $x metabolismus $7 D000072737
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prognóza $7 D011379
- 650 12
- $a infekce papilomavirem $x komplikace $x imunologie $7 D030361
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a dlaždicobuněčné karcinomy hlavy a krku $x imunologie $7 D000077195
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Plačková, Klára $u Sotio Biotech a.s, Prague, Czech Republic $u Department of Otorhinolaryngology and Head and Neck Surgery, Motol University Hospital, Prague, Czech Republic $u 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Pavelková, Lucie $u Sotio Biotech a.s, Prague, Czech Republic $u Department of Otorhinolaryngology and Head and Neck Surgery, Motol University Hospital, Prague, Czech Republic $u 1st Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Aquino-Perez, Cecilia $u Sotio Biotech a.s, Prague, Czech Republic
- 700 1_
- $a Santegoets, Saskia J $u Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands $1 https://orcid.org/0000000228744402
- 700 1_
- $a Laco, Jan $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Grega, Marek $u Department of Pathology and Molecular Medicine, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Dundr, Pavel $u Department of Pathology, General University Hospital, Prague, Czech Republic
- 700 1_
- $a Němejcová, Kristýna $u Department of Pathology, General University Hospital, Prague, Czech Republic
- 700 1_
- $a Hodek, Miroslav $u Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Bouček, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Zábrodský, Michal $u Department of Otorhinolaryngology and Head and Neck Surgery, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Vošmiková, Hana $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Halaška, Michael J $u Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Rob, Lukáš $u Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Prague, Czech Republic
- 700 1_
- $a Čelakovský, Petr $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Chrobok, Viktor $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Iheme, Munachiso Ndukwe $u Department of Gynecology and Obstetrics, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Práznovec, Ivan $u Department of Gynecology and Obstetrics, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Vošmik, Milan $u Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Katina, Stanislav $u Sotio Biotech a.s, Prague, Czech Republic $u Masaryk University, Brno, Czech Republic
- 700 1_
- $a Cibula, David $u Department of Gynaecology, Obstetrics and Neonatology, General University Hospital, Prague, Czech Republic
- 700 1_
- $a Ryška, Aleš $u Fingerland Department of Pathology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a van der Burg, Sjoerd H $u Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands
- 700 1_
- $a Špíšek, Radek $u Sotio Biotech a.s, Prague, Czech Republic
- 700 1_
- $a Fialová, Anna $u Sotio Biotech a.s, Prague, Czech Republic fialova@sotio.com $1 https://orcid.org/0000000314365142 $7 stk2007393943
- 773 0_
- $w MED00201262 $t Journal for immunotherapy of cancer $x 2051-1426 $g Roč. 13, č. 9 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40998518 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20251014 $b ABA008
- 991 __
- $a 20251023075714 $b ABA008
- 999 __
- $a ok $b bmc $g 2416762 $s 1259695
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 13 $c 9 $e 20250925 $i 2051-1426 $m Journal for immunotherapy of cancer $n J Immunother Cancer $x MED00201262
- LZP __
- $a Pubmed-20251014